Finance & Stock Market News

Ranbaxy to supply Nexium raw material in Dec-Jan

Mon, 26th Oct 2009 05:58

NEW DELHI, Oct 26 (Reuters) - Ranbaxy Laboratories, India's top drugmaker by sales, will start supplying in December or January a key ingredient to AstraZeneca for anti-ulcer drug Nexium, Ranbaxy CEO Atul Sobti told reporters on a conference call.

(Reporting by Devidutta Tripathy; Editing by Jarshad Kakkrakandy)

((devidutta.tripathy@thomsonreuters.com; +91 11 4178 1009; Reuters Messaging: devidutta.tripathy.reuters.com@reuters.net)) Keywords: RANBAXY/NEXIUM

(If you have a query or comment on this story, send an email to news.feedback.asia@thomsonreuters.com)

COPYRIGHT
Copyright Thomson Reuters 2009. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.

Related Shares: Astrazeneca (AZN).

Next Article: UPDATE 1-Deloitte says 2009 global revenue falls 4.9 pct

Back to Finance News

Share Price, Share Chat, Stock Market news at lse.co.uk

Member Services
Completely FREE with online Share Chat!
FREE Portfolio and Personalised Watchlist

Datafeed and UK data supplied by ProQuote. While London South East do their best to maintain the high quality of the information displayed on this site, we cannot be held
responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.